Bonner General Health in Sandpoint, Idaho, has selected Mayo Medical Laboratories as its primary reference laboratory. This selection gives Bonner General Health access to Mayo Clinic’s extensive menu of laboratory tests and clinical...
Education on this topic decreases misdiagnosis and the possibility of misinterpreting the comments provided by the reporting laboratories.
Helicobacter pylori - Insights
Find out why timely, accurate diagnosis of H. pylori is critical for improving patients’ gastrointestinal health and preventing further harm.
Pathology consultation - Insights
Learn more about how Mayo Clinic Laboratories consultative pathology practice, which is supported by more than 100 board-certified pathologists, can provide expertise on any case.
Comprehensive panels - Insights
Check out Mayo Clinic Laboratories’ comprehensive pharmacogenomic panels, which identify genetic variations associated with treatment response.
Purine and pyrimidine metabolism disorders - Insights
Check out how Mayo Clinic Laboratories’ genetic testing can help to diagnose and monitor patients affected by purine and pyrimidine metabolism disorders.
In vitro diagnostics solutions - Insights
BioPharma Diagnostics supports medical device, biopharma, and diagnostic companies with in vitro diagnostic services, including analytical validation of new assays and devices in compliance with CAP/CLIA requirements.
Pharmaceutical solutions - Insights
We believe the pharmaceutical industry and clinical research partners can improve global health through innovative drug discovery and development — and that you deserve the best reference lab partner at your side. Mayo Clinic BioPharma...
Mayo Clinic Laboratories’ genetic counselors are experts on heritable illness who provide a wealth of knowledge to guide appropriate testing utilization and interpret results.
Learn more about how our flexible lab space and expert staff can help you meet your diagnostic needs.
Mayo Clinic Laboratories’ targeted testing for opioids uses high-resolution mass spectrometry to detect 33 different opioids.
Mayo Clinic Laboratories’ targeted benzodiazepine testing uses high-resolution mass spectrometry to identify 27 different benzodiazepines and metabolites in the urine.
Precision mental and behavioral health therapeutics - Insights
Our Precision Mental and Behavioral Health Therapeutics initiative leverages cutting-edge diagnostic solutions to optimize medication management for psychiatric and neurologic patients.
Emergency toxicology - Insights
Mayo Clinic Laboratories’ emergency toxicology testing can help providers manage overdose by clarifying whether symptoms are due to the presence of drugs.
New tests launched in September - Insights
In September 2022, Mayo Clinic Laboratories announced ten new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Myelodysplastic syndrome - Insights
Browse our wide variety of testing options for the prognosis and risk stratification associated with myelodysplastic syndrome.
See how our Special Coagulation Laboratory offers algorithmic approaches to meet your bleeding disorder testing needs.
Disease-specific panels - Insights
Learn how disease-specific cancer panels help providers understand their patients’ risk of having a hereditary cancer syndrome.
Comprehensive panels - Insights
Learn how our in-depth genetic testing can determine whether a cancer is hereditary in origin for individuals with a family history of cancer.
Hereditary Colon Cancer Testing - Mayo Clinic Laboratories
Our algorithmic approach aids with the ordering process and guides physicians to ensure the right tests are being ordered at the right time for patients.
Autoimmune Dementia Testing - Mayo Clinic Laboratories
Our phenotype specific testing for autoimmune dementia contains only clinically relevant antibodies providing accurate answers for treatment guidance.
Next-generation sequencing - Insights
Learn more about the advantages offered by Mayo Clinic Laboratories’ next-generation sequencing panel for plasma cell neoplasms.
Children's Oncology Group - Insights
Learn how our team’s commitment and large testing menu helps in meeting the specific needs of Children’s Oncology Group patients.
Learn how our muscular dystrophy genetic testing can help patients access variant-specific therapies and determine eligibility for clinical trials.
Hereditary hearing loss - Insights
Learn how our hereditary hearing loss test can help avoid unnecessary workups and appointments and reduce anxiety for patients and their families.
Amyloidosis Testing - Mayo Clinic Laboratories
Mayo Clinic’s amyloid protein identification methodology is considered the gold standard because of the high sensitivity and accuracy with which it types amyloid proteins in paraffin-embedded specimens.
Mayo Clinic Laboratory and pathology research roundup: September 12 - Insights
This week's research roundup feature: Activated mast cells in periprosthetic joint infection-associated tissue.
Mayo Clinic Laboratory and pathology research roundup: August 15 - Insights
This week's research roundup feature: Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis.
Mayo Clinic Laboratory and pathology research roundup: August 22 - Insights
This week's research roundup feature: Association of plasma biomarkers of Alzheimer Disease with cognition and medical comorbidities in a biracial cohort.
Mayo Clinic Laboratory and pathology research roundup: July 4 - Insights
This week's research roundup feature: Emergence of inducible macrolide resistance in mycobacterium chelonae due to broad-host-range plasmid and chromosomal variants of the novel 23S rRNA methylase gene, erm(55).
Mayo Clinic Laboratory and pathology research roundup: July 25 - Insights
This week's research roundup feature: The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms.
Mayo Clinic Laboratory and pathology research roundup: June 13 - Insights
This week's research roundup feature: Plasma biomarkers for prediction of Alzheimer's disease neuropathologic change.
Mayo Clinic Laboratory and pathology research roundup: May 9 - Insights
This week's research roundup feature: Proprotein Convertase Subtilisin/Kexin Type 6 (PCSK6) is a likely antigenic target in membranous nephropathy and nonsteroidal anti-inflammatory drug use.
Mayo Clinic Laboratory and pathology research roundup: May 16 - Insights
This week's research roundup feature: Development and validation of an acute respiratory distress syndrome prediction model in Coronavirus Disease 2019: Updated lung injury prediction score.
Necrotizing Autoimmune Myopathy [Test in Focus] - Insights
Necrotizing autoimmune myopathy (NAM) is a serious but rare muscle disease strongly associated with autoantibodies to either the protein signal recognition particle (SRP) or the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase...
Should You Worry if You Accidentally Swallow an Insect? - Insights
During summer activities, it's bound to happen. But how dangerous is it to accidentally swallow a bug? Bobbi Pritt, M.D., a microbiologist, pathologist, and Director of the Clinical Parasitology Laboratory at Mayo Clinic in Rochester,...
Cytopathology Services at Mayo Clinic Laboratories
Pathologists from across the world send cases for the cytopathology section at Mayo Clinic to review. Learn more.
See how our comprehensive fluorescence in situ hybridization panels simplify the ordering process to ensure every patient receives the right test.
Pioneering Research in Autoimmune Neurology: Vanda Lennon, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by Vanda Lennon, M.D., Ph.D., founder of the Neuroimmunology Laboratory and now...
Reflex Test Guides Precise Care for Arsenic Exposure: Paul Jannetto, Ph.D. - Insights
Paul Jannetto, Ph.D., explains how Mayo Clinic Laboratories' SPAS test identifies the form of arsenic present in patients with arsenic exposure. That information is important for determining the potential level of harm and for removing the...
Novel Laboratory Tests Transform Lupus Management: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, is joined by special guests Bernard Rubin, D.O., MPH, chief medical officer of Progentec Diagnostics, and Melissa...
Beyond Q-tips: The swabbing guide for SARS-CoV-2 - Insights
This "Phlebotomy Webinar" will discuss the various types of swabs that can be used to collect specimens for SARS-CoV-2 molecular testing.
Improvements to downtime process, form provide clarity for clients - Insights
The downtime process and form have been improved to provide clear guidance on the steps clients should take during downtime.
New tests launched in April - Insights
In April 2023, Mayo Clinic Laboratories announced 10 new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
This “Specialty Testing” webinar will discuss the collaborative effort which led to the discovery of Kelch like protein 11 (KLHL11) IgG as a specific biomarker of neurological autoimmunity associated testicular germ cell tumor.
Blood Diversion/Culture Contamination - Insights
PACE / State of FLThis “phlebotomy webinar” will address the evidence behind blood diversion as a mechanism to lower blood culture contamination rates and discuss the experience at Mayo Clinic Rochester with a pilot of one blood diversion...
Monitoring Tropical Storm Helene - Insights
Tropical Storm Helene is approaching the Florida Gulf Coast and is expected to become a hurricane. These weather conditions may impact areas in the United States, including Alabama, Florida, Georgia, and South Carolina. We continue to...
New tests launched in September - Insights
In September 2021, Mayo Clinic Laboratories announced seven new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Labor Day Specimen Shipment Alert - Insights
Due to the Labor Day holiday (recognized on Monday, September 5th), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, plan ahead.
Introduction to Cost of Quality in the Laboratory - Insights
This "Phlebotomy" webinar will provide an introduction to cost of quality. The main components of the presentation will include discussions on the cost of attaining quality and the cost of poor quality.